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Open access under CC BYNuclear Magnetic Resonance (NMR) studies with hyperpolarized (hp) noble gases are at an exciting inter-
face between physics, chemistry, materials science and biomedical sciences. This paper intends to pro-
vide a brief overview and outlook of magnetic resonance imaging (MRI) with hp noble gases other
than hp 3He. A particular focus are the many intriguing experiments with 129Xe, some of which have
already matured to useful MRI protocols, while others display high potential for future MRI applications.
Quite naturally for MRI applications the major usage so far has been for biomedical research but perspec-
tives for engineering and materials science studies are also provided. In addition, the prospects for surface
sensitive contrast with hp 83Kr MRI is discussed.
 2012 Elsevier Inc. Open access under CC BY license.1. Introduction
Although magnetic resonance imaging (MRI) of the gas phase is
possible without the use of hyperpolarized (hp) spin states [1], the
density of gases at ambient pressure and temperature is typically
reduced by about three orders of magnitude compared to the
respective condensed phase. This signiﬁcantly lowers Nuclear
Magnetic Resonance (NMR) signal intensities and limits magnetic
resonance imaging (MRI) resolution as the MRI experiments re-
quire gases with high gyromagnetic ratio, c, high spin concentrations,.ac.uk (T. Meersmann).
 license.and shorter longitudinal (T1) relaxation times (to allow for rapid
signal averaging). Hp spin states, on the other hand, can enhance
the NMR signals by many orders of magnitude compared to ther-
mally polarized states and enable gas phase MRI of both dilute spin
systems and nuclei with low gyromagnetic ratios. Since the hyper-
polarization is almost always produced outside the MRI detection
region, the hp gas typically requires some form of transport from
the hyperpolarizer to the detection zone and sufﬁciently long
relaxation times are needed to sustain the generated hyperpolar-
ized state until NMR signal detection has occurred. There is no dis-
advantage from slow T1 relaxation in hyperpolarized MRI because
signal averaging is not based on relaxation recovery but on re-
newed delivery of hyperpolarized species for every scan.
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gas phase due to spin–rotation interactions. A noticeable exception
is the group of mono-atomic noble gases where spin–rotation
relaxation only occurs during short-lived interaction with other
atoms [2]. Therefore T1 times of many hours and even days can
be possible unless additional relaxation mechanisms are present
[2–5].
To date, the most widespread and successful MRI applications of
hp noble gases utilize the isotope 3He (spin I = ½, NMR frequency
75.905 MHz at 2.35 T) for preclinical and clinical studies of pulmon-
ary pathophysiology. A review of the successful applications with
hp 3HeMRI would exceed the purpose of this paper and is therefore
best left to the specialists in this ﬁeld (see for instance [6–8] for pre-
vious reviews). Furthermore, the main supply source for 3He is tri-
tium decay in nuclear (fusion) warheads with no viable current
alternative in sight. The very high demand for this isotope for many
types of applications has therefore led to a 3He supply crisis as evi-
denced by US congressional hearings [9]. The best remedies to this
problem for the MR community may be rigorous 3He recycling
whenever possible and the exploration of alternative techniques.
Hp 129Xe, in particular, has found applications in medical re-
search but, unlike 3He, also has been used in materials science,
chemistry and related disciplines where the large 129Xe chemical
shift range is exploited for NMR spectroscopy [10–17]. Therefore,
hp 129XeMRI is at a stimulating interface between physical and bio-
medical sciences and this article focuses on actual and prospective
hp 129Xe MRI methods in many research ﬁelds. In addition, hp 83Kr
MRI which exploits the nuclear electric quadrupole moment of this
noble gas isotope for surface sensitive contrast will also be covered.2. Hp 129Xe MRI
Next to 3He, the most prominent noble gas isotope for hp gas
phase MRI is 129Xe that has already found its way into preclinical
and clinical usage. Indeed, the ﬁrst noble gas lung MRI reported
by Albert et al. in 1994 utilized hp 129Xe [18]. The isotope 129Xe
has a nuclear spin I = –1/2 with an NMR frequency of 27.6 MHz
at 2.35 T magnetic ﬁeld strength (i.e. 100 MHz 1H frequency) for
elemental xenon at ambient pressure and temperature. Xenon is
a renewable resource obtained from air liquefaction with a natural
abundance of 26.4% 129Xe and isotopic enrichment is available at
affordable costs (i.e. currently US$ 200–250 per liter gas at ambient
pressure and temperature, depending on the ﬂuctuating actual
market and speciﬁc offers. Xenon gas with natural abundance iso-
tope distribution typically costs around US$ 10–12 per liter gas).
The signal intensity of 129Xe falls short compared to that of hp
3He because of the 2.74 times larger gyromagnetic ratio of 3He
and because of the high spin polarizations routinely obtained with
3He that exceeded those typically achieved for 129Xe.
For a hyperpolarized spin system, the NMR signal intensity is
proportional to the square of the gyromagnetic ratio assuming
identical conditions with respect to the polarization value P, mag-
netic ﬁeld strength B0, spectral width, and NMR hardware. How-
ever, the signal losses due to electrically conducting, whole body
sized media at typical MRI ﬁeld strengths (1.5 T and above) in-
creases with higher frequencies. For whole body hp 129Xe and hp
3He MRI applications one therefore usually assumes only a linear
dependence of the MR signal intensity on the gyromagnetic ratio.
In addition, depending on the particular application, the disadvan-
tage for 129Xe and its lower resonance frequency may be further re-
duced at higher ﬁeld strengths because its smaller gyromagnetic
ratio means less shortening of the T2 values (generally caused by
magnetic susceptibility effects in heterogeneous media such as
the lungs). In addition, due to ever increasing progress in spin
exchange optical pumping (SEOP), very high 129Xe polarizationvalues have now been reached at high production rates [19–23].
This has ultimately reduced the SNR gap between 3He and 129Xe,
directly improving the temporal and spatial resolution of hp
129Xe imaging. Optimization of hardware and MRI protocols leads
to further advances in the quality of the MR images. See Fig. 1
for an example of the ‘evolution’ of hp 129Xe lung MRI over the past
two decades [24].3. Hp noble gas production
A hyperpolarized spin state is simply a state at very low spin
temperature that is not in a thermal equilibrium with the (mo-
tional) temperature of the sample. Low spin temperature leads to
high population of the ground state and thus high magnetization
of the spin ensemble that results in very high NMR signal intensity.
This state eventually returns to the thermal equilibrium tempera-
ture (i.e. depolarizes). Therefore, T1 relaxation needs to be slow en-
ough to preserve the state for sufﬁcient periods of time. The
hyperpolarized state can, in principle, be generated through rapid
heating of a sample from the thermal equilibrium at very low tem-
peratures (T 1 K) [25]. Experimentally less demanding, all noble
gas isotopes with non-zero nuclear spin can be hyperpolarized
through spin exchange optical pumping (SEOP) using alkali metal
vapor [26]. Although SEOP is typically performed at temperatures
above 350 K and under high power laser irradiation, it selectively
reduces the temperature of the nuclear spin to values far below
1 K. For this to be useful for MRI, the reactive alkali metal (typically
rubidium) needs to be removed before the hp gas is transferred for
MRI detection [27,28]. Slow T1 relaxation is needed to preserve the
low spin temperature that is not in a thermal equilibrium with the
molecular environment. The nuclear spin polarization of a hyper-
polarized sample is best determined through the signal enhance-
ment factor obtained from comparison of the associated hp NMR
signal with that of a thermally polarized sample at otherwise iden-
tical – or at least at comparable – conditions. At ambient temper-
atures and high magnetic ﬁeld strengths, the thermal spin
polarization can be straightforwardly calculated using:
Ptherm ¼ jcjhB03kBT ðI þ 1Þ ð1Þ
where I is the nuclear spin, c is the gyromagnetic ratio, kB is the
Boltzmann constant, and h ¼ h2p is the Planck constant [29]. The
polarization Php of the hp sample is simply the product of Ptherm
and the SEOP enhancement factor. SEOP can be performed either
in a stopped ﬂow mode [27,30,31] or in a continuous ﬂow mode
[20]. Typically SEOP uses a mixture of gases that contain xenon
(or krypton) in low concentrations and N2 and helium (4He) in
abundance. Though low noble gas concentration reduces the MR
signal intensity, hp 129Xe can be concentrated through cryogenic
separation [19,20,23,32,33].
Many advances have been made in continuous ﬂow SEOP lead-
ing to very high spin polarization values at high production rates
[19–23,32,34,35]. At the pinnacle of current technology, Hersman
and co-workers have developed a fully automated SEOP system
with cryogenic separation that is capable of producing multiple li-
ters of hp 129Xe per hour with a spin polarization Php = 50% [19,36].
Batch mode SEOP, as a potential low cost alternative, is being fur-
ther developed using various approaches by other groups [30,31].
For example high noble gas concentration at low pressures in batch
mode SEOP has been recently explored to bypass the need for cryo-
genic separation [31]. This method produced the equivalent of hp
129Xe gas with Php = 14% at a rate of 1.8 cm3/min using only 23W
of laser power. For hp 83Kr, where cryogenic separation is not fea-
sible due to rapid quadrupolar relaxation in the frozen state, the
method allowed for Php = 3% at a rate of 2.0 cm3/min.
Fig. 1. Evolution of hp 129Xe image resolution over a decade. (A) Early image of a rat lung from 1998 with in-plane resolution 0.84  0.84 mm2 and SNR of 3. (B–D)
Progressively better image quality as polarization, gas delivery and MR acquisition techniques continue to improve. (D) Image from 2007 with resolution 0.31  0.31 mm2
and an SNR of 20. Reprinted with permission from Driehuys et al. Toxicol. Pathol. 2007; 35:55.  SAGE Publications.
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larize 129Xe together with a reactive gas. This has been demon-
strated in SEOP of CH4–Xe mixtures that served as fuel for hp
129Xe MRI of combustion [37]. Methane as a saturated hydrocarbon
compound shows little afﬁnity to react with rubidium under SEOP
conditions. The polarization obtained in a 5% Xe, 10% N2, and 85%
CH4 mixture was Php = 7% in continuous ﬂow mode at 40
cm3/min and Php = 40% in batch mode SEOP.
One crucial element in the improvements of SEOP systems are
the many advances made in solid-state laser technology. Line-
narrowed laser output at growing power levels becomes increasingly
available and affordable [38]. Furthermore, an alternative method-
ology of potential interest for hp noble gas MRI has recently been
explored. Dynamic nuclear polarization (DNP) at 1.2 K was re-
ported as a new approach to generate hp 129Xe state at potentially
high volumes [39]. Whatever methodology will ultimately be the
most successful, the proliferation of techniques to conveniently
and inexpensively polarize noble gases appears likely. One should
therefore expect for hp noble gas MRI to move beyond its current
usage limited to highly specialized research facilities.Fig. 2. Hp 129Xe slice selective coronal MR images (in red) overlayed onto
corresponding proton thoracic images from healthy volunteers and subjects with
asthma, chronic obstructive pulmonary disease (COPD), cystic ﬁbrosis (CF) and
radiation-induced lung injury (RILI). Reprinted with permission from Shukla et al.
Acad. Radiol., 2012; 19:944,  2012 Elsevier. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)4. Hp 129Xe MRI – Gas phase perspectives
4.1. Hp noble gas phase imaging in vivo
Possibly the most useful applications of simple spin density gas
phase imaging of hp noble gases are in lung functional studies. The
clinically most relevant parameter that can be garnered from static
pulmonary ventilation scans are ventilation defects [40]. In pa-
tients with chronic obstructive pulmonary disease (COPD) or asth-
ma it is possible to monitor the evolution of these defects as the
diseases progress over time during clinical, longitudinal studies.
It is also possible to observe the response to airway hyperrespon-
siveness tests in asthma [41]. Effective ventilation deduced by hp
MRI in vivo has been shown to correlate with spirometry data for
patients in health and disease [40,42]. However, although the hp
noble gas ventilation images may appear dramatic when display-
ing larger unventilated areas in lungs it should be noted that this
might not be necessarily speciﬁc to one disease pathology, rather
they reveal the extent and severity of ventilation defects that
may be common in many conditions (Fig. 2, [43]).
Safe in vivo delivery of hp noble gases merits special mention-
ing. In general, static ventilation imaging is performed during a
simple breath hold after inhalation of the gas mixture containing
a known volume of hp gas. Oxygen, can be added to the hp gas
for inhalation but paramagnetic O2 also leads to an increase in
relaxation, for instance the T1 value drops to approximately 15 s
for 129Xe in breathable mixtures containing 20% O2 [44]. Special
care should be taken as xenon becomes a general anesthetic when
its alveolar concentration is in the realm of 70% [45]. However a
Fig. 3. Comparison of signal amplitude between two trains of 127 pulses using
constant ﬂip angle (FLASH) of 12 (a) and variable ﬂip angle (VFA) (b) methods.
Experimental data are represented by the dots, while the solid lines represent
theoretical predictions. Reprinted with permission from Zhao et al. J. Magn. Reson.
Ser. B, 1996; 113:180.  1996 Elsevier.
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of 20–40 s, will usually only result in an alveolar concentration of
xenon  35% [46]. Moreover, it has been recently reported that
3–4 repeated inhalation cycles with undiluted one liter boluses
of hp 129Xe are well tolerated in patients with mild to moderate
COPD [47].
The most common in vivo hp noble gas imaging protocols are
still using the concept of FLASH (Fast-Low-Angle-Shot) as their
core. Variable ﬂip angle (VFA) MRI sequences, ﬁrst developed by
Zhou et al. [48], are based on an innovative concept that makes full
use of the entire hp spin state and therefore lead to improved MR
image quality. VFA results in constant signal amplitude (assuming
the absence of noticeable T1 relaxation) until the hp state is com-
pletely ‘used up’ (Fig. 3) [48]. Although this methodology has rarely
been used for MRI of lungs to date, as it requires careful calibration
of the rf pulse power, it can be tremendously beneﬁcial for exper-
iments where low signal intensity is a concern [49],
Technological developments in hardware, computing and image
reconstruction might lead to orders of magnitude faster data col-
lection and processing compared to the ﬁrst in vivo attempts.
Improvements utilizing echo planar imaging (EPI) and spiral imag-
ing acquisition schemes are already in place for dynamic ventila-
tion imaging with hp 3He, however spatial resolution is usually
sacriﬁced for speed. Three-dimensional (3D) dynamic imaging
with hp 3He within one breath-hold has also been reported [50].
These improvements might be translated to other hp noble gases
(129Xe, 83Kr) given that sufﬁcient advances in SEOP of these species
will be achieved.Fig. 4. Joint spatial–velocity images of xenon Poiseuille ﬂow in a pipe (id = 4 mm, DXe =
while the y-axis represents spatial location across the pipe with 0 mm referring to the p
(A) Computer simulation with D = 10 ms. (B) Experiment with D = 10 ms. (C) Experime
permission from Kaiser et al. J. Magn. Reson. 2001; 149:145.  2001 Elsevier.4.2. Dispersion and velocimetry in the gas phase
NMR and MRI velocimetry methods have been extensively re-
viewed [51]. In principal, the methods can be translated directly
to study gas phase ﬂow and dynamics though experiments must
be designed with consideration to the speciﬁc requirements for
gas phase measurements. In non-turbulent ﬂow of liquids, the
coherent motion dominates, while contributions from the stochas-
tic dispersion (i.e. diffusion driven) term are negligible. In ﬂowing
gases however, stochastic terms may be on the same order of mag-
nitude as the coherent terms arising from the ﬂow. As shown in
Fig. 4, this can lead to a strong interplay between coherent ﬂow
and Brownian motion depending on the time D between the gradi-
ent pulses used for displacement encoding.
Whilst at shorter D times xenon displaces as predicted numer-
ically (Fig. 4a and b), velocity proﬁles of xenon for longer D times
manifest temporal (i.e. D dependent) progression of molecular dis-
placements [52]. As D becomes longer, dispersion averages the ra-
dial dependence of the coherent displacements and results in
velocity proﬁles as displayed in Fig. 4c and d. Therefore, special
care needs to be taken in choosing NMR parameters during ﬂow
experiments to account for these averaging effects. Nonetheless
ﬂow and dispersion can still be probed at a wide range of temporal
and spatial scales [51] leading to valuable information in many
applications. A novel example is the measurement of gas ﬂow
within a ﬂame using a continuous ﬂow of a CH4–hp 129Xe fuel mix-
ture. MRI of the entire ﬂame region is possible due to the combus-
tion resistance of the 129Xe hyperpolarized state [37]. Velocimetric
measurements in lungs are also feasible but are experimentally
demanding since they cannot be performed in a continuous ﬂow
mode. However, some examples using ventilation synchronized
measurements have been reported with hp 3He [53].4.3. Apparent diffusion coefﬁcient (ADC) measurements in vivo
As detailed in the velocimetry section, the results of gas phase
pulsed ﬁeld gradient (PFG) ﬂow measurements may display a
dependence upon D (i.e. the time between gradient pulses used
for displacement encoding). This D dependence is due to the inter-
play of ﬂow and diffusion driven dispersion. Even in the absence of
ﬂow, pure diffusion measurements can display a D dependence if
the gas is contained in a porous medium. For sufﬁciently short D
times, the result of the PFG experiments will measure unrestricted
diffusion and therefore the same diffusion constant Do as in the
free gas. As D becomes longer, the mean displacement of the gas4.5 mm2/s, Vave = 20 mm/s). The x-axis represents axial velocity (i.e. in z-direction)
ipe center. The spectral window in the ﬂow-encoding dimension was kept constant.
nt with D = 60 ms. (D) Experiment with D = 130 ms. Adapted ﬁgure, printed with
D.M.L. Lilburn et al. / Journal of Magnetic Resonance 229 (2013) 173–186 177will be hindered by the pore walls, resulting in a reduced apparent
diffusion coefﬁcient (ADC).
Diffusion of hp gases in lungs is restricted by alveolar walls and
ADC measurements can therefore provide valuable information
about lung morphometry [54,55]. Work with 3He (binary diffusion
coefﬁcient of dilute 3He in air (D3HeAir ¼ 0:86 cm2=s) [56]) has
shown that in cases of alveolar destruction such as in emphysema-
tous disease the ADC becomes elevated [57,58]. The ADC measure-
ments for 129Xe (D129XeAir ¼ 0:14 cm2=s [56]) correlate with those
for 3He [59] with ADC values elevated in human COPD phenotypes
[60]. Recently, it has been found that 129Xe ADC values may actu-
ally correlate better than 3He ADC with other lung function testing
methods. This may be possibly due to the lower rate of diffusion of
xenon leading to less contamination through collateral ventilation
from neighboring alveoli [61]. Note, that the 129Xe self-diffusion
coefﬁcient is six times smaller than that of 3He therefore larger
ﬁeld gradients are required to perform the ADC measurements
on similar 3He time scales. This puts a strain on the hardware
safety requirements, however experimental strategies have been
proposed to circumvent this problem [62].5. Hp 129Xe MRI – Dissolved phase perspectives
5.1. The 129Xe chemical shift
As 3He has a negligible chemical shift and low solubility, its dis-
solved phase, if any, does not bring any additional information. The
situation is different for xenon. Due to its large compressible outer
electron shell, 129Xe exhibits a signiﬁcant chemical shift when
placed into different chemical environments as compared to the
gas phase. The 129Xe NMR chemical shift range is just below
300 ppm for the various materials and solvents that may absorb
the xenon atoms [11,12,15,16]. Note, that 129Xe NMR signal inFig. 5. (a) NMR spectrum of hyperpolarized 129Xe from a sample that contains gas phase
fragments (around 25 ppm). (b) 2-D slice of 3-D chemical shift selective MRI of the bulk g
shift selective MRI using the 25 ppm signal with rising recycle delay times s that lead t
indicates a high concentration of hp 129Xe within the aerogel fragments. Inspection of (c–
to reduced ﬂow between the particles. Adapted ﬁgure, printed with permission from K
Sciences, USA.the bulk gas phase approximated to zero pressure is typically ref-
erenced with 0 ppm and the shift increases by about of 0.6 ppm/
bar in pure xenon gas at ambient temperature and pressure condi-
tions close to ideal gas behavior. There is an extensive literature
covering hyperpolarized 129Xe NMR spectroscopy in addition to
work with thermally polarized 129Xe that utilizes the chemical
shift as a ‘spy’ for the environment of the xenon atoms. However,
with the recent advances in hyperpolarization of this nucleus,
the interrogation of dissolved xenon chemical shift has excellent
perspectives for MRI applications in materials science and biomed-
ical studies.5.2. Transport weighted MRI contrast
129Xe chemical shift selective imaging can be used to visualize
the effects of gas transport in porous media [63,64]. In conven-
tional MRI, the variation of the recycle delay can lead to T1 relaxa-
tion weighted contrast. In hp MRI, the variation of recycle delay
may produce a gas transport weighted contrast if hp 129Xe is con-
tinuously delivered. The gas is hyperpolarized outside the super-
conducting magnet and its transport into the sample through
ﬂow and diffusion will take time. After a 90 excitation pulse, all
hp 129Xe within the detection region has been depolarized and
the following scan will only detect any signal if the recycle delay
is long enough to permit for renewed hp 129Xe delivery. This allows
for the unique transport weighted contrast that provides a ‘snap-
shot’ of the gas penetration into porous samples as shown in
Fig. 5. Note that the xenon concentration in the sample is constant
in time but the ‘concentration’ of the hp nuclear spin state is time
dependent. The application of depolarizing radiofrequency (RF)
pulses requires that new hp gas is delivered into the material dur-
ing the recycle delay. At constant recycle delays, a steady state is
generated that can be imaged [64].xenon (close to 0 ppm depending on pressure) and xenon occluded within aerogel
as phase (0 ppm) surrounding the aerogel fragments. (c–e) 2-D slice of 3-D chemical
o an increasing penetration of the hp 129Xe into the material. High signal intensity
e) reveals that the penetration into the aerogel fragments is strongly anisotropic due
aiser et al. P. Ntl. Acad. Sci. USA. 2000; 97:2415-6.  2000 National Academy of
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The chemical shift of 129Xe is also very useful for pulmonary
MRI where continuous ﬂow hp 129Xe transport is replaced by usage
of the breathing cycle for delivery. When coupled with xenon’s
high solubility, it is possible to record a distinct signal arising from
xenon atoms associated only with parts of lungs where xenon dis-
solves, i.e. lung tissue and its components. The ﬁrst in vivo hp 129Xe
spectra showed four resolved peaks, the initial one located at the
gas phase set to 0 ppm and three other peaks were found at 191,
199 and 213 ppm and were attributed to 129Xe dissolved in blood
plasma, lung tissue and red blood cells (RBCs), respectively
(Fig. 6) [65]. The longitudinal relaxation of the peaks associated
with the dissolved phase was found to be on the order of seconds
thus allowing for the possibility to image xenon incorporated into
the tissue components separately from the gas phase [66].
Chemical shift selective MRI of dissolved xenon in lungs is facil-
itated by the signiﬁcant frequency shift between 129Xe in the gas
phase (around 0 ppm) and in the dissolved phase (191–213 ppm)
[67]. Unfortunately, xenon in the dissolved phase constitutes only
about 1–2% of the total inhaled xenon. Therefore, the associated hp
129Xe signal intensity arising from the dissolved phase is fairly
weak. Therefore, Fig. 6 does not reﬂect the true intensity of the
gas phase peak because the excitation frequency was selected for
the 200 ppm region. If full broadband excitation would be applied,
the gas phase peak should be about 50–100 times stronger than
the dissolved signal. However, the dissolved phase xenon is con-
stantly replenished from the alveolar gas phase through rapid dif-
fusive exchange. Thus, chemical shift selective excitation of the
dissolved phase (i.e. that does not depolarized the hp 129Xe in
the gas phase) allows for signal averaging with very short delay
times in the millisecond regime. Fujiwara and coworkers have
demonstrated the use of continuous delivery of hp gas in the
mouse lung as a method to enhance the dissolved phases signal
[68,69]. Single breath-hold and chemical shift selective three-
dimensional MRI of the dissolved phases in human volunteers with
reasonable spatial resolution have also been reported [70,71].
This concept can be used for new physiological measurements
that probe gas transfer in lungs using xenon as a surrogate for oxy-
gen and may be helpful for early diagnosis of interstitial lung dis-
eases such as idiopathic pulmonary ﬁbrosis (IPF). Due to aFig. 6. One of the earliest hp 129Xe spectra and washout dynamics from the rat pulmonar
B and C at 191, 199, 213 ppm relative to the gas phase peak at 0 ppm attributed to the blo
129Xe washout with the combined effects of ventilation, RF depletion and longitudinal r
111:301.  1996 Elsevier.thickening of the lung parenchyma that separates the alveolar
space from the blood, gas exchange is reduced in these diseases
and gas transport requires longer time periods. Driehuys et al. ex-
plored the exchange between the alveolar membrane and capillary
blood using a technique called xenon alveolar capillary transfer
imaging (XACT) [72]. The technique uses chemical shift selective
separation between tissue and blood dissolved hp 129Xe utilizing
the 14 ppm difference between the two dissolved states. The slo-
wed gas transfer from the alveoli to the blood can be visualized
with hp 129Xe if short recycle delays are used as shown in Fig. 7.
The underlying concept of XACT is chemical shift selected
recovery of the hp 129Xe signal. This method has been explored
by Butler and co-workers to measure surface area to volume ratios
(SA/Vgas) in a variety of porous media and has been applied later in
a non-spatially resolved manner to study morphometry of healthy
human lungs in vivo [73,74]. After a series of selective 90 pulses
has destroyed the dissolved phase magnetization and created an
initial zero point, the increase of the dissolved phase signal is re-
corded as a function of time. Assuming that one dimensional diffu-
sion drives signal growth of the dissolved phase one can deduce
the SA/Vgas in lungs from the dissolved phase to gas phase signal ra-
tio. Recently, this model was reﬁned with lung blood ﬂow correc-
tions and was used to determine additional parameters including
alveolar septal thickness (h) [75]. The surface area to volume ratio
was found to decrease in healthy subjects with increasing inhala-
tion volumes as expected and was noted to be lower in patients
with COPD, indicating airspace destruction. The septal thickness
was seen to be signiﬁcantly raised in patients with mild interstitial
lung disease.
Xenon transfer contrast (XTC) is an alternative approach to ﬁght
the relatively weak hp 129Xe signal originating from the dissolved
phase through the usage of indirect detection of the dissolved
phase in the gas phase [76]. The underlying principle is that hp
129Xe exchanges not only from the gas phase to the dissolved phase
but also vice versa from the tissue into the alveolar space. There-
fore, chemical shift selective destruction of the hp 129Xe magneti-
zation (i.e. saturation) in the dissolved phase by 90 pulses can
be observed indirectly through a reduction of alveolar hp 129Xe
gas phase signal. The advantage is that the alveolar signal is much
stronger and hence easier to detect. The reduction of the signal is
measured in comparison with experiments without chemical shifty system. (a) Hp 129Xe spectra at t = 0 after inhalation of the last xenon bolus. Peak A,
od plasma, lung tissue and red blood cells respectively. (b) Temporal dynamics on hp
elaxation. Reprinted with permission from Sakai et al. J. Magn. Reson. Ser. B, 1996;
Fig. 7. Inhaled hp 129Xe images from saline treated rat (sham) and bleomycin treated rat (ﬁbrosis model). Images (A–C) from sham instillation of saline into the left lung. (A)
Gas phase 129Xe image from the airspaces. (B) Tissue phase 129Xe image from the lung parenchyma. (C) Red blood cell (RBC) phase 129Xe image. (D–F) Comparable images
11 days after bleomycin instillation into the left lung with D, E and F representing the gas phase, tissue phase and RBC phase images respectively. Note that the tissue images
closely match the gas phase images in both rats whilst the RBC phase images show almost absent uptake of 129Xe by the RBCs in the bleomycin treated lung in the time-frame
of the MRI experiment as compared to the sham treated rat, indicating thickening of the alveolar membrane (ﬁbrosis). Reprinted with permission from Driehuys et al. P. Ntl.
Acad. Sci. USA, 2006; 103:18280.  2006 National Academy of Sciences, USA.
Fig. 8. Gas phase image from rat lung with directly inhaled hp 129Xe and delivered
by injection of hp 129Xe in saline solution. The injected image shows a signal void
corresponding to the right main stem bronchus (arrow). Reprinted with permission
from Driehuys et al. Radiology, 2009; 252:390.  2009 Radiological Society of North
D.M.L. Lilburn et al. / Journal of Magnetic Resonance 229 (2013) 173–186 179selective saturation. Since the concept is based on gas exchange, it
allows for regional measurement of gas diffusion into the
parenchyma.
To obtain spatial information the XTC preparatory sequences
are usually combined with FLASH imaging protocol. To further
maximize the image contrast the signal associated with the dis-
solved phase can be inverted rather than suppressed [77,78]. Infor-
mation is obtained from the decrease of the gas phase signal after
multiple exchange times during the XTC sequence as it is propor-
tional to the surface to volume ratio between the lung parenchyma
and airspaces. Consequently, the increase of the gas phase signal is
indicative of alveolar membrane thickening. With this in mind re-
gional gas exchange has been probed in healthy humans and sub-
jects with COPD [78]. Reduced surface area that corresponded to
destruction of the airspaces and septal wall thickening resulted
in distinctive contrast in XTC images.America.6.1. In vivo delivery of dissolved 129Xe as a contrast agent
As 129Xe is reasonably soluble in saline solution, it can also be
added to physiological solutions and then injected into the blood
stream [79]. The T1 relaxation time of hp 129Xe is in excess of
60 s in saline solution, reduces to 13 s in oxygenated blood, and
is further shortened in deoxygenated blood [80,81]. After intrave-
nous injections, the hp 129Xe is delivered through the blood stream
(i.e. via perfusion) and subsequent diffusion through the lung
parenchyma into the alveolar gas phase. A lack of alveolar hp
129Xe indicates either inhibited perfusion or thickening of the lung
parenchyma. The MR contrast in these images is thus indicative to
vital lung function such as perfusion and blood–gas exchange. It is
instructive to compare these images with ventilation sensitive MRI
where hp 129Xe is delivered through direct inhalation (see Fig. 8).
The intravenous delivery method suffers however from low xenon
signal intensity and is limited by the volume of saline that can
safely be infused in vivo. The use of hollow-ﬁber membranes has
however allowed continuous delivery of xenon [82] and thus has
resulted in improved detection of the hp 129Xe dissolved phase in
the lungs [83].Dissolved phase hp 129Xe imaging can also be applied in vivo to
non-respiratory body systems and adds a novel complementary
investigative tool for neuroimaging. The ﬁrst spectra and chemical
shift images using inhaled hp 129Xe delivered to the brain through
the bloodstream were acquired by Swanson et al. [84]. Intra-arte-
rial deliveries of hp 129Xe dissolved in lipid emulsions and gas mi-
cro-bubbles were utilized to improve transport to the cerebral
circulation but image quality was again limited by the quantities
and the time-frame for hp 129Xe delivery [85,86], particularly as
the longitudinal relaxation time of 129Xe dissolved in the rat brain
in vivo was thought to be of a similar order to that required for up-
take by cerebral tissues [87]. After correction for in vivo SNR levels,
rat brain T1 times were found to be 15.3 ± 1.2 s and 16.2 ± 0.9 s
using two separate protocols [88]. Meanwhile Kershaw, Nakamura
and coworkers independently helped to unravel the complex dis-
solved phase spectra from the rat brain [89,90]. The group found
that a complex system of ﬁve peaks was reliably resolvable after
meticulous shimming. The group demonstrated that the dominant
peak arises from brain tissue, presumably from the grey matter
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white matter.
Images of middle cerebral artery occlusions in rats have since
been acquired that demonstrate the absence of the dissolved hp
129Xe signal in regions with acute ischemia and the poorly perfused
surrounding penumbra (Fig. 9) [91]. Moreover, functional brain
images produced during painful stimuli in rats displayed enhanced
cerebral hp 129Xe uptake in areas of the brain that largely corre-
sponded to sensory regions previously identiﬁed by proton func-
tional MRI methods [92]. Though 129Xe images are of lower
spatial and temporal resolution than 1H arterial spin labeled
(ASL) images, a great correlation between the two techniques adds
another delightful perspective for the possible use of hp 129Xe in
functional brain imaging and diagnosis.7. Towards molecular imaging using functionalized 129Xe
biosensors and HYPER-CEST
Molecular imaging, i.e. the detection of the spatial distribution
of speciﬁc target molecules in an organism provides tremendous
opportunities for biomolecular research. The challenge for molecu-
lar MRI lies in the inherent complexity of NMR spectra and the low
signal intensity typically associated with dilute concentrations of
the target molecules. One pathway, that has attracted a great deal
of attention, is dynamic nuclear polarization (DNP) of molecules
that are isotopically labeled at speciﬁc sites, resulting in NMR spec-
tra with high signal intensity and manageable complexity [93].
However, the large chemical shift range of 129Xe and the simplicity
of typical 129Xe NMR spectra opens up an alternative approach to
molecular imaging. In 2001, Pines, Wemmer, and co-workers
undertook the ﬁrst step into molecular MRI using hp 129Xe [94]
and the underlying concept, developed by this group, bears signif-Fig. 9. (a) Proton apparent diffusion coefﬁcient (ADC) map image post right middle cer
<5.30  0104 mm2/s (circled by blue line). (b) Corresponding hp 129Xe chemical shift i
brain tissue and an obvious signal void corresponding to the ischemic core. (c) 2,3,5-triph
map based on the ADC and TTC images shown in (a) and (c) with healthy brain tissue (gre
et al. Nmr Biomed. 2011; 24:173.  2011 John Wiley and Sons, Inc. (For interpretation of
of this article.)icant potential for future biomedical applications [95,96]. The fun-
damental idea is, reminiscent of ﬂuorescence labeling, to use bio-
sensor molecules that contain bioactive ligands with a speciﬁc
binding afﬁnity for particular analytes (Fig. 10). In the original
work, biotin as a ligand for the protein avidin was used but the
concept can be extended from peptide–antigen recognition as
shown by Schlund et al. [97], to speciﬁc binding to nucleotide
targets as demonstrated through in vitro recognition of a DNA
strand by Berthault and co-workers [98], and to cancer biomarkers
as reported by Dmochowski and co-workers [99,100]. Linked via a
molecular tether to the speciﬁc ligand is an encapsulating agent,
such as a cryptophane cage, that can bind a single xenon atom.
129Xe bound to the cages will resonate at a chemical shift that is
distinct from the resonance of the xenon dissolved in the solvent
and that is speciﬁc for the type of encapsulating cage used. Further,
the 129Xe chemical shift observed in the cage changes slightly
between protein-bound and unbound biosensors, presumably be-
cause of distortions in the cage structure. The cages are required
to have a high binding afﬁnity for xenon but also need to allow
for fast exchange with the hyperpolarized xenon atoms in solution,
yet slow enough to prevent coalescence of the chemical shift
differences. Useful exchange rates should therefore be somewhere
in the 10–100 Hz regime. Cryptophanes [101,102] are the most
widely studied xenon encapsulating molecules as they have a
high binding afﬁnity, allow for sufﬁcient exchange, and provide a
large (chemical shift) shielding for the encapsulated xenon atoms
due to the presence of aromatic rings. Particularly useful
properties for biomedical applications are that the cages can be
chemically modiﬁed and that several water-soluble cryptophanes
with large xenon binding afﬁnity have been synthesized
[103–105].
For hyperpolarized 129Xe MR bio-detection, the biosensor mol-
ecule is administered long before the hp 129Xe is transferred toebral artery occlusion. Ischemic core (absent perfusion) is indicated by ADC values
mage displayed in arbitrary units with the greatest signal originating from healthy
enyltetrazolium chloride (TTC)-stained brain section of the same animal. (d) Tricolor
en), ischemic core (red) and penumbra (blue). Reprinted with permission from Zhou
the references to color in this ﬁgure legend, the reader is referred to the web version
Fig. 10. Hp 129Xe biosensor approach. (a) Cryptophane-A cage, acting as a xenon encapsulating agent, tethered to a bioactive ligand (red) with a speciﬁc binding afﬁnity for
avidin. (b) Full spectrum (bottom): actual hp 129Xe spectrum of the biosensor in the absence of avidin. The signal at 193 ppm is from xenon in solution (i.e. water) while the
signal at 70 ppm corresponds to xenon in the cryptophane-A cage of the biosensor molecule shown in (see inset i). The signal at 71 ppm originates from xenon in
cryptophane-A cages without tether. When avidin is added, another signal appears (ii) just below 73 ppm. Adapted ﬁgure, printed with permission from Spence et al. P. Ntl.
Acad. Sci. USA, 2001; 98:10655.  2001 National Academy of Sciences, USA. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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injection [106] or simply through inhalation. Relaxation within
the cages is on the order of many tens of seconds and thus will
interfere little with the detection scheme. Since different cages
with distinct 129Xe chemical shifts and different binding moieties
can be used concurrently, the simultaneous recognition of different
target molecules, i.e. multiplexing, is possible [94,107].
7.1. HYPER-CEST
The scheme described above allows for MRI detection of
(multiple) immobilized biosensors bound to targets present in a
stationary matrix. Since the hp 129Xe can be delivered in excess,
biosensor detection in the micro-molar regime is possible. Thesensitivity can be signiﬁcantly increased further through an indi-
rect detection method developed by Pines and co-workers [108].
HYPER-CEST is a combination of CEST (chemical exchange satura-
tion transfer) with hp 129Xe and is reminiscent of the concept de-
scribed for XTC above. Chemical shift selective irradiation at the
129Xe frequency of the bound xenon is applied to destroy the
hyperpolarized state. Chemical exchange between bound xenon
and xenon in the bulk solution (for instance blood) then leads to
a depletion of the bulk solution hp 129Xe signal as long as the irra-
diation is applied. The signal reduction is indicative of the biosen-
sor presence and therefore of the target molecule. Because the
129Xe signal arising from the bulk solution is much stronger than
that from the bound xenon, and because the depletion can be
‘accumulated’ over time, HYPER-CEST allows for nano-molar sensi-
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tion level in the solution does not signiﬁcantly ﬂuctuate due to
other causes.
Additional ways to boost sensitivity for xenon-biosensors are in
the usage of dendrimer–cryptophane supramolecular constructs
[109] and viral capsid scaffolds [110] that both increase the num-
ber of cages per target molecule. Further, functionalized zeolite
nano-particles have also been explored as potential biosensors
[111]. The advantage of these particles is that they may accommo-
date a copious amount of xenon atoms leading to a stronger di-
rectly detected signal.
8. Remote detection
The concept of gas MRI can be extended by a remote detection
scheme developed by Pines and co-workers [112] where the exci-
tation coil and pulsed magnetic ﬁeld gradient coils are completely
separated in space from the detection coil. In this scheme, hp 129Xe
is delivered to the sample region where the excitation and encod-
ing take place. The hp 129Xe is then transferred to a distant detec-
tion region where the encoded information is read out with a
higher sensitivity than what would be possible in the sample re-
gion. In its most basic form, this scheme does not have a direct
dimension (such as frequency encoding) and requires point-by-
point measurement of the encoded phase for all dimensions. The
long hp 129Xe T1 relaxation facilitates the experiments as the en-
coded information is stored as ‘‘magnetization’’, despite the 50%
signal loss associated with the use of a storage pulse analogue to
that in stimulated echo sequences. After storage, the information
transport can take place via gas ﬂow to a distant detection cell
where the encoded information is read after another excitation
pulse. Gas mixing during transport typically does not cause prob-
lems for the read out of the stored spatial information as long as
there is no mixing between the individual point-by-point experi-Fig. 11. Remotely detected images of gas ﬂow through the rock sample for various arriva
the ﬂuid ﬂows through a sample, the nuclear spin magnetization is modulated by RF pu
sample, the 129Xe magnetization is recorded when it arrives at the detection coil. (a) 3
encoding. Reprinted ﬁgure with permission from Granwehr et al. Phys. Rev. Lett., 2005;ments. The main advantage of this technique is that the encoding
and detection regions can be independently optimized, the former
for versatility of the encoding and the latter can be optimized for
sensitivity. An increased sensitivity could be achieved using a coil
that may be smaller than the actual sample leading to an improved
ﬁlling factor and the detection ﬁeld strength may be higher than in
the sample region. This scheme allows for samples to be used that
could not be measured sensitively in an NMR experiment, such as a
magnetic porous material. The mobile phase can be encoded with-
in this porous substance while the detection will be spatially re-
moved from the material. Alternatively, detection methods that
are not based on Faraday inductive detection may be employed
to provide higher sensitivity [113,114].
While remote detection does not contain a direct spectral or
imaging dimension, the arrival of the encoded gas can be moni-
tored transiently, thereby retrieving time-of-ﬂight information in
a direct dimension. This enables visualization of ﬂow and diffusion
through, for example, a porous rock sample [115] or through
microﬂuidic devices [116,117]. The gas from various regions (and
therefore the encoded information) may arrive at different times
(of ﬂight) as shown in Fig. 11. The 129Xe chemical shift can also
be utilized in remotely detected MRI to separate between different
environments of the gas ﬂowing through porous systems [118].
Perhaps most interesting for biomedical applications, is that the re-
mote detection concept can be extended to MRI of dissolved xenon
with detection after extraction from the liquid to the gas phase via
membranes [119]. Remote detection of hp gases can also be uti-
lized for relaxation measurements and may be particularly useful
for ﬁeld dependent relaxometry studies [120].
As a note of caution, remote detection suffers from the absence
of a direct dimension (i.e. there is no frequency encoding) because
the information has to be collected point by point. For instance, a
64  64 two-dimensional MR image requires a minimum of 4096
scans as opposed to 64 scans for directly detected MRI. On thel times (i.e. time between encoding and detection) as indicated above each image. As
lses and magnetic ﬁeld gradients to encode its spatial coordinates. After leaving the
D representation, (b) time of ﬂight x–z images with varying detection times after
95:075503-3.  2005 American Physical Society.
Fig. 12. (A) Photograph of a sample containing 1.0 mm glass beads with a siliconized, hydrophobic surface in compartment (i) and an untreated, hydrophilic surface in
compartment (ii). (B) MRI of gas phase hp 83Kr shortly after transfer into the sample. (C) Hp 83Kr MRI as in (B) but after additional 6 s delay time, showing a surface sensitive
MRI contrast. The 83Kr quadrupolar relaxation caused by surface interactions leads to T1 = 9 s in the hydrophobic region (i) and to T1 = 35 s in the hydrophilic region (ii).
Adapted ﬁgure, printed with permission from Pavlovskaya et al. P. Ntl. Acad. Sci. USA 2005; 102:18278  2005 National Academy of Sciences, USA.
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which facilitates a different type of direct dimension than in con-
ventional Fourier imaging techniques. Therefore continuous ﬂow
type of experiments are probably most practical for remote detec-
tion. Further, remote detection also requires that ﬂuctuations in
the gas delivery and spin polarization are kept at a minimum
although calibration experiments can sometimes correct for such
ﬂuctuations [120].9. Hp 83Kr MRI
One of the advantages of hp 129Xe MRI is the associated large
chemical shift that is indicative of small distortions in xenon elec-
tron cloud and is therefore a valuable probe of the atomic and
molecular surrounding. The 129Xe chemical shift is unsurpassed
by any other stable noble gas isotope. However, 131Xe, another
NMR active and stable xenon isotope, has a nuclear spin I = 3/2
and therefore possesses a nuclear electric quadrupole moment that
can also serve as a fairly sensitive detector of atomic electron cloud
distortions. It is therefore a much more sensitive probe for noble
gas–surface interactions than the 129Xe chemical shift and the iso-
tope can provide surface sensitive MRI contrast [121]. Unfortu-
nately, even gas phase collisions cause rapid quadrupolar driven
relaxation that leads to short 131Xe T1 times and therefore rapid de-
cay of the hyperpolarized state [29]. However, another noble gas
isotope with a nuclear electric quadrupole moment, namely 83Kr,
typically displays a slower quadrupolar relaxation compared to
131Xe because of krypton’s smaller electron cloud and because of
its larger nuclear spin I = 9/2. The remarkably long 83Kr gas-phase
T1 times of up to several hundred seconds at ambient pressure al-
low for hyperpolarization up to P = 26%. Because of dilution with
other gases, the best currently available apparent (i.e. effective)
polarization is 3% [31].
The quadrupolar longitudinal 83Kr relaxation can be utilized for
MR studies of surrounding surfaces since it is susceptible to the
surface-to-volume ratio, surface hydration, and surface tempera-
ture [28]. Hyperpolarized (hp) 83Kr has been shown to provide T1
relaxation weighted MRI contrast that is highly sensitive to the
surface chemistry in low surface-to-volume model systems.
Fig. 12 provides an example of surface sensitive contrast in hp
83Kr gas phase MRI. Hp 83Kr NMR relaxation measurements of ex-
cised but actively ventilating rat lungs have been used recently to
study T1 relaxation as a function of lung inﬂation [122]. The longi-
tudinal 83Kr relaxation in the distal airways and the respiratory
zones was found to be independent of the lung inhalation volume
and highly reproducible between different specimens. The T1 relax-
ation times ranged between 1.0 and 1.3 s and should be long en-
ough for in vivo usage of hp 83Kr MRI with rats that typically
breathe at a rate of around 1 Hz while anesthetized. Further, the
relaxation should be slower in larger animals if surface to volumeratio decrease with larger alveoli diameters. A spatially resolved
relaxation study may provide insights into alveolar recruitment
and may also be indicative of diseases that affect lung surface to
volume ratios or the chemical composition of the lung surface,
for instance through alterations of the surfactant concentration.
Recent improvements in SEOP have increased the hp 83Kr signal
intensity signiﬁcantly [31] and enabled coronal lung FLASH MRI
of excised rat lungs in unpublished, preliminary studies.
As some ﬁnal notes, krypton is obtained from air liquefaction at
approximately tenfold lower cost than xenon – i.e. on the order of
US$ 0.80–1.00 per liter gas. Unfortunately, due to rare demand the
costs for isotopically enriched 83Kr is currently about US$ 5000 per
liter. At ambient pressure, krypton has no anesthetic properties
[45]. The isotope 83Kr has a natural abundance of 11.5% and its
NMR resonance frequency in the gas phase at ambient pressure
and temperature is 3.85 MHz at 2.35 T magnetic ﬁeld strength.
As a consequence of its extremely low gyromagnetic ratio, the
83Kr T2 relaxation times are typically much longer than that of
129Xe. Furthermore, due to its low c, the 83Kr T1 relaxation in rat
lungs is not affected by the presence of up to 40% paramagnetic
oxygen [122]. Note that although hp 83Kr may dissolve in many tis-
sues, the useful signal associated with its dissolved phase is lost
owing to fast quadrupolar relaxation.10. Conclusions
Recent and currently ongoing advances in the hp 129Xe produc-
tion, in optimization of MRI methods, and in regulatory compliance
associated with clinical hp 129Xe usage may allow for hp 129Xe MRI
to substitute some of the 3He MRI applications in the intermediate
future. However, hp 129Xe MRI also provides complementary infor-
mation to existing 3He techniques because xenon tissue solubility
and the 129Xe chemical shift allow diagnostic studies of lungs in
health and disease as shown in elegant experiments by a number
of groups. The advent of biosensors promises to extend the scope
of hp 129Xe MRI towards molecular imaging.
Although the materials science and engineering applications for
hp 129Xe have predominately been in NMR spectroscopy, hp 129Xe
MRI should also be attractive for the respective communities. The
potential signiﬁcance of hp 129Xe applications within non-biomed-
ical research ﬁelds is for non-invasive spatially resolved transport
measurements. These applications may involve remote detection
schemes that allow for measurements in materials environments
that usually do not allow for straightforward NMR detection.
Of the quadrupolar noble gas isotopes, 83Kr is most likely ﬁnd
usage as a surface sensitive MRI contrast agent. The currently
available polarization levels allow for proof of principle studies
and ﬁrst applications in pulmonary imaging. The highest beneﬁt
of hp 83Kr MRI contrast will likely be obtained in conjunction with
the higher resolution of hp 129Xe MRI measurements.
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